94 related articles for article (PubMed ID: 11381363)
1. Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events.
Volante M; Tizzani A; Casetta G; Zitella A; Pacchioni D; Bussolati G
Hum Pathol; 2001 May; 32(5):468-74. PubMed ID: 11381363
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y
Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346
[TBL] [Abstract][Full Text] [Related]
3. The loss of 8p23.3 is a novel marker for predicting progression and recurrence of bladder tumors without muscle invasion.
Eguchi S; Yamamoto Y; Sakano S; Chochi Y; Nakao M; Kawauchi S; Furuya T; Oga A; Matsuyama H; Sasaki K
Cancer Genet Cytogenet; 2010 Jul; 200(1):16-22. PubMed ID: 20513529
[TBL] [Abstract][Full Text] [Related]
4. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
6. Molecular clonal analysis of recurrent bladder cancer.
Junker K; Wolf M; Schubert J
Oncol Rep; 2005 Aug; 14(2):319-23. PubMed ID: 16012709
[TBL] [Abstract][Full Text] [Related]
7. Molecular evidence supporting field effect in urothelial carcinogenesis.
Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
[TBL] [Abstract][Full Text] [Related]
8. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genetic alterations in normal bladder urothelium.
Leonardo C; Gallucci M; Cianciulli AM
Urology; 2004 Aug; 64(2):405; author reply 405-6. PubMed ID: 15302516
[No Abstract] [Full Text] [Related]
10. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
[TBL] [Abstract][Full Text] [Related]
11. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
12. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
[TBL] [Abstract][Full Text] [Related]
13. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
14. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M
J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of aneusomy of chromosomes in exfoliated urothelial cells to predict the recurrence of superficial bladder cancer after complete transurethral resection].
Bao QB; Liu J; Sun HB; Su JH; Zhu JG; Lin JZ
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):548-51. PubMed ID: 19567078
[TBL] [Abstract][Full Text] [Related]
17. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
18. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L
Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846
[TBL] [Abstract][Full Text] [Related]
19. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
20. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]